Citation Impact
Citing Papers
A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression
2007
Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression
2009
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins
2009
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
Bispecific antibodies for cancer therapy
2009
Current knowledge on exosome biogenesis and release
2017 Standout
Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence
2015
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
2011
Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes
2012
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer
2020
MYC on the Path to Cancer
2012 Standout
EVALUATION OF URINE N1,N12-DIACETYLSPERMINE AS POTENTIAL TUMOR MARKER FOR URINARY BLADDER CANCER
2006
Impaired DICER1 function promotes stemness and metastasis in colon cancer
2013
The Blood–Brain Barrier
2015 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
2007
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
2008
Translational Control in Cancer Etiology
2012
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage
2011
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
Antibodies in oncology
2011
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Antibody therapy of cancer
2012 Standout
Cancer stem cells: In the line of fire
2012
Structure of mammalian eIF3 in the context of the 43S preinitiation complex
2015 StandoutNatureNobel
Direct reprogramming of stem cell properties in colon cancer cells by CD44
2011
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
Regulation of protein stability by GSK3 mediated phosphorylation
2009
Claudin interactions in and out of the tight junction
2013
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin
2010
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The cancerous translation apparatus
2011
Hallmarks of Cellular Senescence
2018 Standout
Progress in Exosome Isolation Techniques
2017 Standout
Hidradenitis suppurativa
2020 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Epithelial cell–cell junctions and plasma membrane domains
2008
Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines
2013
Multispecific drugs herald a new era of biopharmaceutical innovation
2020 Nature
Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer
2011
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
2011
Reassessment of Exosome Composition
2019 Standout
A Fluorescent Imaging Probe Based on a Macrocyclic Scaffold That Binds to Cellular EpCAM
2015
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Structure of the Mammalian Ribosomal 43S Preinitiation Complex Bound to the Scanning Factor DHX29
2013 StandoutNobel
Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers
2012
The role of MicroRNAs in human cancer
2016 Standout
Impact of Nanotechnology on Drug Delivery
2009 Standout
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
2013 Standout
Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM)
2018
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
The Many Substrates of Presenilin/γ-Secretase
2011
Antitumor activity of an epithelial cell adhesion molecule–targeted nanovesicular drug delivery system
2007
EpCAM and the biology of hepatic stem/progenitor cells
2014
The RNA Recognition Motif of Eukaryotic Translation Initiation Factor 3g (eIF3g) Is Required for Resumption of Scanning of Posttermination Ribosomes for Reinitiation on GCN4 and Together with eIF3i Stimulates Linear Scanning
2010
Recycling, clustering, and endocytosis jointly maintain PIN auxin carrier polarity at the plasma membrane
2011 StandoutNobel
Lost in migration
2010
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
2015 Standout
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
2018 Standout
Induction of hepatocellular carcinoma by in vivo gene targeting
2012
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
2017
Targeting Notch to Target Cancer Stem Cells
2010
Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
2010
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Comparative Shotgun Proteomics Using Spectral Count Data and Quasi-Likelihood Modeling
2010
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Works of Markus Münz being referenced
Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
2008
A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells
2018
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas
2003
Nuclear signalling by tumour-associated antigen EpCAM
2009
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
2004
Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
2010
The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP
2004
Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation
2006
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
2009